Fever-Tree: still fizzing in the US
The premium mixer group is shaping up to be a rare UK success in the world’s largest market, but it’s journey has really only just begun; the Chairman clearly remains confident, acquiring a large number of shares. We were also impressed with progress from an unusual financial services group. Read on here for our thought on this and other news. (Premium)
Fever-Tree: fizzing in the US and margins on the rise
Fever-Tree: (AIM:FEVR), the creator of superlative premium mixers, reported decent progress in its trading update for the year to December 2023. With costs under better control, we can also look forward to significantly improved margins in 2024.
Group revenue rose 6% to c.£364m, marginally below consensus, with varying degrees of success in its geographical markets.
The US market was the standout performer, growing…
Continue reading our content…
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
- Company and markets insights
- Sponsored content
- Podcasts
Previous article Next article
